Folate-conjugated and pH-responsive polymeric micelles for target-cell-specific anticancer drug delivery
Folate-conjugated and pH-responsive polymeric micelles for target-cell-specific anticancer drug delivery
复制标题
用于靶细胞特异性抗癌药物递送的叶酸缀合和 pH 响应聚合物胶束
DOI:
10.1016/j.actbio.2017.07.018
复制
发表时间:
2017-09-15
影响因子:
9.7
通讯作者:
Zhang, Zheng-Yun
中科院分区:
文献类型:
--
作者:
Guan, Jiao;Zhou, Zun-Qiang;Zhang, Zheng-Yun
In this study, we developed a folate (FA)-conjugated and pH-responsive active targeting micellar system for anti-cancer drug delivery. In this system, FA was attached to the terminal of the hydrophilic segment of poly(lactic acid)-poly(L-lysine) (PLA-PLL), and PLL was modified by a citric acid group. The FA receptor-mediated active targeting and electrostatic interaction between micelles and cell membrane due to a negative-to-positive charge reversal was combined in one micellar anti-cancer drug delivery system to enhance the tumour targeting and cellular internalisation of micelles. In vitro and in vivo anticancer studies demonstrated that the doxorubicin-loaded, FA-conjugated and pH-responsive polymeric micelles possess an enhanced and effective cancer efficiency.Statement of significanceNegatively charged nano-carriers prolonged anti-cancer drugs' blood circulation. However it is difficult to be internalised. Therefore, a negative-to-positive charged micelle surface could improve selectivity for tumour cells and increase uptake chance.Statement of significance: In this study, we developed a folate (FA)-conjugated and pH-responsive active targeting micellar system for anti-cancer drug delivery. The FA receptor-mediated active targeting and electrostatic interaction between micelles and cell membrane due to a negative-to-positive charge reversal was combined in one micellar anti-cancer drug delivery system to enhance the tumour targeting and cellular internalisation of micelles. In vitro and in vivo anti-cancer studies demonstrated that the doxorubicin-loaded, FA-conjugated and pH-responsive polymeric micelles possess an enhanced and effective cancer efficiency. (C) 2017 Published by Elsevier Ltd on behalf of Acta Materialia Inc.